Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran PK/PD in Infants with VTE
NCT02223260Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Sep 2014; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02223260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02223260.